Should you buy DaVita stock? (NYSE:DVA). Let's see how it does in our automated value investing analysis system.
Based on historical returns, we believe that DaVita can grow its free cash at a rate of about 1%. That's positive!
(DaVita stock price per share)
||DVA Fair Price
(based on intrinsic value)
||DVA Safety Price (based on a variable margin of safety)||$65.22|
||PE Ratio versus Sector||3% higher than other Healthcare stocks|
|PE Ratio versus Industry||16% higher than other Medical Care stocks|
|Free Cash Flow Jitter||24%|
We believe that DaVita may be worth examining further. It's making money, which is a very positive sign. Is it on sale?
DaVita looks like a price in the fair value range. Based on our analysis—if the company keeps making money the way it has been—you could be looking at a good stock. See Before You Buy for your next steps.
Does DaVita have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
Most Popular Articles